URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Mahlon Johnson

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentPathology and Laboratory Medicine
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester NY 14642
Other Positions
TitleDirector, Neuropathology
InstitutionSchool of Medicine and Dentistry
DepartmentPathology and Laboratory Medicine

 
 Awards And Honors
1976     Phi Kappa Phi
1980     Alpha Omega Alpha Medical Honor Society
1982 - 1984NIH National Research Service Award
1984     Sigma Xi Excellence in Research Award
2001     Pathology Residents Teaching Award, Anatomic Pathology
 
 Overview
Dr. Johnson's primary research interest is in the growth regulation of the leptomeninges and meningiomas.

 
 Selected Publications
  • Somers KE, Almast J, Biemiller RA, Silberstein HJ, Johnson MD, Mohile NA. Diagnosis of primary CNS melanoma with neuroimaging. J Clin Oncol. 2013 Jan 1; 31(1):e9-e11.
    View in: PubMed
  • Johnson MD, O'Connell M, Iqbal MA, Williams JP. Radiation effects on human leptomeningeal cell response to cerebrospinal fluid and PDGF-BB. Int J Radiat Biol. 2012 Jul; 88(7):547-55.
    View in: PubMed
  • Powers JM, Johnson MD. Mycoplasmal panencephalitis: a neuropathologic documentation. Acta Neuropathol. 2012 Jul; 124(1):143-8.
    View in: PubMed
  • Johnson MD, O'Connell M, Facik M, Maurer P, Jahromi B, Pilcher W. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3. J Neurooncol. 2012 Mar; 107(1):121-31.
    View in: PubMed
  • Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S. MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro Oncol. 2011 Apr; 13(4):447-55.
    View in: PubMed
  • Johnson MD, Shaw AK, O'Connell MJ, Sim FJ, Moses HL. Analysis of transforming growth factor ß receptor expression and signaling in higher grade meningiomas. J Neurooncol. 2011 Jun; 103(2):277-85.
    View in: PubMed
  • Johnson MD, O'Connell M, Pilcher W. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism. J Neurooncol. 2011 Feb; 101(3):441-8.
    View in: PubMed
  • Johnson MD, O'Connell MJ, Pilcher W, Reeder JE. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. J Neurosurg. 2010 May; 112(5):934-9.
    View in: PubMed
  • Johnson MD, Vito F, Xu H, Xu H. MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain. Appl Immunohistochem Mol Morphol. 2010 May; 18(3):250-3.
    View in: PubMed
  • Liu Y, Carson-Walter EB, Cooper A, Winans BN, Johnson MD, Walter KA. Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol. 2010 Aug; 99(1):13-24.
    View in: PubMed
  • Carson-Walter EB, Winans BN, Whiteman MC, Liu Y, Jarvela S, Haapasalo H, Tyler BM, Huso DL, Johnson MD, Walter KA. Characterization of TEM1/endosialin in human and murine brain tumors. BMC Cancer. 2009; 9:417.
    View in: PubMed
  • Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA. Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. J Neurooncol. 2010 May; 98(1):83-92.
    View in: PubMed
  • Johnson MD, O'Connell MJ, Vito F, Pilcher W. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol. 2009 Nov; 68(11):1177-83.
    View in: PubMed
  • Lin WC, Sandberg DI, Bhatia S, Johnson M, Morrison G, Ragheb J. Optical spectroscopy for in-vitro differentiation of pediatric neoplastic and epileptogenic brain lesions. J Biomed Opt. 2009 Jan-Feb; 14(1):014028.
    View in: PubMed
  • Johnson MD, Moots PL, Zhuang Z, Weil RJ. Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia. Ann Clin Lab Sci. 2009; 39(3):295-302.
    View in: PubMed
  • Johnson MD, O'Connell M, Vito F, Bakos RS. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas. J Neurooncol. 2009 Apr; 92(2):129-36.
    View in: PubMed
  • Mentrikoski M, Johnson MD, Korones DN, Scott GA. Glioblastoma multiforme in skin: a report of 2 cases and review of the literature. Am J Dermatopathol. 2008 Aug; 30(4):381-4.
    View in: PubMed
  • Johnson MD, Vito F, O'Connell MJ. Mesothelin expression in the leptomeninges and meningiomas. J Histochem Cytochem. 2008 Jun; 56(6):579-85.
    View in: PubMed
  • Johnson MD, Fan X, Bourne P, Walters D. Neuronal differentiation and expression of neural epitopes in pituitary adenomas. J Histochem Cytochem. 2007 Dec; 55(12):1265-71.
    View in: PubMed
  • Johnson MD, Sade B, Milano MT, Lee JH, Toms SA. New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol. 2008 Jan; 86(1):109-22.
    View in: PubMed
  • Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery. 2007 Jul; 61(1 Suppl):327-35; discussion 335-6.
    View in: PubMed
  • Majumder SK, Gebhart S, Johnson MD, Thompson R, Lin WC, Mahadevan-Jansen A. A probability-based spectroscopic diagnostic algorithm for simultaneous discrimination of brain tumor and tumor margins from normal brain tissue. Appl Spectrosc. 2007 May; 61(5):548-57.
    View in: PubMed
  • Johnson MD, Stevenson CB, Thompson RC, Atkinson J, Boyer P. December 2006: 31-year-old woman with hemiparesis. Brain Pathol. 2007 Apr; 17(2):255-7.
    View in: PubMed
  • Johnson MD, Floyd JL, Caprioli RM. Proteomics in diagnostic neuropathology. J Neuropathol Exp Neurol. 2006 Sep; 65(9):837-45.
    View in: PubMed
  • Johnson M, Pace J, Burroughs JF. Fourth ventricle rosette-forming glioneuronal tumor. Case report. J Neurosurg. 2006 Jul; 105(1):129-31.
    View in: PubMed
  • Mangels KJ, Johnson MD, Weil RJ. 35-year-old woman with progressive bilateral leg weakness. Brain Pathol. 2006 Apr; 16(2):183-4, 187.
    View in: PubMed
  • Desai J, Shannon ME, Johnson MD, Ruff DW, Hughes LA, Kerley MK, Carpenter DA, Johnson DK, Rinchik EM, Culiat CT. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet. 2006 Apr 15; 15(8):1329-41.
    View in: PubMed
  • Johnson M, Toms S. Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy? J Neuropathol Exp Neurol. 2005 Dec; 64(12):1029-36.
    View in: PubMed

Visualizations


Johnson's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department